|Gavin Coleman (ESR); obtained his B.Sc in Medicinal Chemistry and Chemical Biology, from University College Dublin, Ireland in 2013. He commenced his further studies in July 2013 within CBNI, investigating novel dendrimeric targeting structures for navigating the biological environment. Since October 2015, Gavin has been seconded to an Early Stage Researcher fellow position within NanoClassifier for 9 months. His work within NanoClassifier is focused on exploring how variations in shape have an impact on how nanoparticles interact with different proteins and biomolecules.|
|Dr Stephanie Devineau (ER); is a Marie Curie postdoctoral fellow at the Centre for BioNano Interactions.
After completing an MSc in Earth Sciences at Ecole Normale Superieure de Lyon, she obtained an MSc in Chemistry and a PhD in Chemistry from Paris-Sud University. She completed her PhD at the French Atomic Energy Agency on the physicochemical and the biochemical aspects of the interactions of proteins with nanoparticles. After her PhD, she joined the group of Prof. Damien Baigl at Ecole Normale Superieure, Paris, where she developed a low-resource diagnostic tool of sickle cell hemoglobin in drops, in collaboration with Henri Mondor hospital. Then, she obtained a JSPS Summer program fellowship and joined the Molecular Spectroscopy Laboratory at RIKEN, Japan, to study protein charge at interfaces by sum frequency generation spectroscopy. She joined CBNI in 2016 to investigate the immune response to nanoparticles in vivo in relation with the development of nanoparticle-based vaccines.
|Laurence Fitzpatrick (ESR); obtained his B.Sc in Science and Nanotechnology, from Dublin Institute of Technology, Ireland in 2012. He commenced his Ph.D. studies in September 2012, funded by the Irish Research Council under the EMBARK Initiative. His Ph.D. to date has focused on quantitative analysis of nanoparticle uptake using various imaging techniques. Since October 2015, Laurence has been recruited to an Early Stage Researcher fellow position within NanoClassifier. His work within NanoClassifier is focused on furthering our understanding of Bio-Nano Interactions by looking at the interactions of nanoparticles with cell surface receptors using the QCM for direct interaction measurements.|
|Dr Maria Gianneli (ER); holds a PhD in Materials Science and Technology from the University of Crete, Greece. Her PhD research was funded by a Marie – Curie Host Fellowship and the largest part of the project was completed at the Max Planck Institute for Polymer Research (MPI-P) in Mainz, Germany. Her previous postdoctoral research was funded by the European Union project “Love wave fully integrated Lab-on-Chip platform for food pathogen detection”, focusing on the detection of whole bacteria using acoustic wave sensors. Since July 2015, she is employed by Attana AB, Sweden, in the Nanoclassifier Project where she employs QCM for rapid label-free bio-nano-interface evaluation. Currently she is designing and executing binding assays to analyze interaction kinetics and affinity studies of nanoparticles with or without biomolecular coronas to different cell lines.
|Dr Hender Lopez Silva (ER); obtained his PhD in Electronic Engineering from the Universidad Autonoma de Barcelona, Spain in 2010. From 2011 to 2013, he worked at the Mathematical Science Department at Loughborough University were his research focus was on Mathematical Modelling of Complex Liquids. From 2013 to 2015 he was part of the UCD team of the EU project MembraneNanoPart developing computational models to simulate the interactions of Nanoparticles with Proteins and Lipids. From the end of 2015, he joined the CBNI at UCD were he has continued to develop computational and mathematical models to study nano-biointeraction. His focus in the NanoClassifier project is to understand the influence of the fluid flow on the measurements performed by the QCM.
|Steffi Suja Thomas (ESR); obtained her B.Sc. in Science with Nanotechnology from Dublin Institute of Technology (DIT), Ireland in 2013. She commenced her PhD studies in September 2013 in Centre for Bio-Nano Interactions (CBNI) and was funded by Irish Research Council. Her project focuses on synthesis of novel silica based platform nanoarchitectures for improved biological detection and sensing. From July 2016, Steffi has been seconded to an Early Stage Researcher with the NanoClassifier for 9 months. Her work in the NanoClassifier will focus on the design and characterization of varying pegylated nanoparticles and the interactions with biological media.|
|Dr Yan Yan (ER); obtained her PhD in Biochemistry and Molecular Biology from Peking University, China in 2008. Subsequently, she pursued her postdoctoral training in the field of nanotechnology focusing on advanced drug delivery in oncology using nanoparticles at University of Melbourne, Australia from 2008 to 2012. From Jan 2013 to May 2015, Dr Yan held an Australian Research Council Discovery Early Career Researcher Award, working as a research fellow at University of Melbourne. Since May 2015, she has taken the recruited fellow position in Nanoclassifier Project at UCD, Ireland. Through the Nanoclassifier project, Dr Yan has obtained expert training in studying bionanointerface. Currently she is focusing on developing new technique platforms for advancing targeted nanoparticle-enabled drug delivery.
|Dr Davide Proverbio (ER); graduated from Milano Bicocca University in 2009 with an MSc in medical biotechnology and subsequently obtained the PhD in biochemistry from the Goethe University in Frankfurt am Main. During his work, focused on the Cell-Free expression of GPCRs, he became especially interested in biophysical characterization of proteins and biosensor technologies. Davide joined Attana in 2014 working as application scientist. His work within NanoClassifier is focused on exploring bio-nano interactions using QCM technology.|
|Dr Diluka Peiris (ER); obtained her PhD in Biochemistry from University of Westminster, U.K. in 2009 and pursued her post-doctoral training in cancer glycobiology in the same department. In 2014, she joined Attana AB as an Application specialist. She has been involved in the development of QCM based cell platform to characterise nanoparticle interactions with cellular surface. She has developed a platform to characterise bio-nano interface and cell binding partners in complex biological environment.|